Peptide

Epitalon Course

A synthetic tetrapeptide associated with ageing research, with limited clinical evidence.

AvailabilityClinical & regulatory review required

A consultation does not guarantee that a product can be supplied.

Background

What it is, how it developed and why it is discussed

Epitalon is a synthetic tetrapeptide derived from research around pineal peptide preparations. It is often promoted for longevity, but strong evidence for clinically meaningful anti-ageing outcomes is not established.
Evidence

Evidence, limitations and clinical context

Registration and scheduling in South Africa must be verified before supply. Direct online sale is disabled by default.
Clinical access

Availability requires regulatory confirmation

Online purchase remains disabled until the exact human-use product, South African registration and scheduling have been verified. A clinical assessment can still be booked to discuss appropriate options.

Clinical assessment Clinician authorisation